Abstract
The Dense Tissue and Early Breast Neoplasm Screening-2 (DENSE-2) trial addresses whether supplemental contrast-enhanced mammography and abbreviated MRI can lead to fewer interval cancers in women with extremely dense breasts compared with mammography.
Funding Information
  • ZonMw (05550412310002)

This publication has 29 references indexed in Scilit: